MatthewCaseyRiddleJr.MD
Endocrinology • Portland, ORDiabetes, Lipid Metabolism
Professor of Medicine, Oregon Health & Sci University
Are you Dr. Riddle?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-5732Fax+1 503-494-5883
Summary
- Dr. Matthew Riddle Jr., MD is an endocrinologist in Portland, Oregon. He is currently licensed to practice medicine in Oregon. He is a Professor of Medicine at Oregon Health & Sci University.
Education & Training
Harvard Medical SchoolClass of 1964
Certifications & Licensure
OR State Medical License 1967 - 2023
Publications & Presentations
PubMed
- 1 citationsEffect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial.Rahul Aggarwal, Deepak L Bhatt, Michael Szarek, Christopher P Cannon, Lawrence A Leiter
The Lancet. Diabetes & Endocrinology. 2025-04-01 - ADO09, a co-formulation of pramlintide and insulin A21G, lowers body weight versus insulin lispro in type 1 diabetes.Grit Andersen, Rosy Eloy, Tim Heise, Martin Gaudier, Claire Mégret
Diabetes, Obesity & Metabolism. 2024-10-01 - 1 citationsEffects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF.Ankeet S Bhatt, Deepak L Bhatt, Ph Gabriel Steg, Michael Szarek, Christopher P Cannon
Journal of the American College of Cardiology. 2024-09-17
Press Mentions
Type 2 Diabetes Remission: New Guidelines Outline the Steps to Follow with a DoctorSeptember 7th, 2021- Type 2 Diabetes ‘Remission’ Is a Reality, Say Major OrganizationsSeptember 1st, 2021
Dulaglutide Reduces Cardiovascular Disease in People with Type 2 DiabetesJune 9th, 2019- Join now to see all
